PF-06869206

N/A

Report date: 2023/09/13 14:21:47
NME

Base Information

Drug NamePF-06869206
Drug Alias NamePF-06869206
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium-dependent phosphate transport protein 2B inhibitors
TargetsSodium-dependent phosphate transport protein 2B
Therapy Area/IndicationsHyperphosphatemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsHyperphosphatemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A